Bottom line
How much do VHT and VGHCX overlap?
55% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 52.6% of VHT's assets and 47.0% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.
VHT holds far more positions (407 vs 97), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings VHT and VGHCX have in common
| Holding | % of VHT | % of VGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.04% | 8.61% | 8.61% |
| Johnson & Johnson | 8.47% | 4.83% | 4.83% |
| AbbVie Inc | 6.09% | 2.30% | 2.30% |
| UnitedHealth Group Inc | 5.45% | 4.05% | 4.05% |
| Merck & Co Inc | 4.66% | 5.44% | 4.66% |
| Intuitive Surgical Inc | 2.38% | 2.52% | 2.38% |
| Danaher Corp | 1.84% | 2.18% | 1.84% |
| CVS Health Corp | 1.83% | 2.52% | 1.83% |
| Vertex Pharmaceuticals Inc | 1.80% | 2.36% | 1.80% |
| Elevance Health Inc | 1.35% | 1.83% | 1.35% |
| Boston Scientific Corp | 1.13% | 1.53% | 1.13% |
| Regeneron Pharmaceuticals Inc | 1.00% | 2.14% | 1.00% |
| HCA Healthcare Inc | 0.96% | 1.68% | 0.96% |
| Edwards Lifesciences Corp | 0.79% | 2.56% | 0.79% |
| Cencora Inc | 0.79% | 2.47% | 0.79% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in VHT
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Pfizer Inc — 2.35%
- Abbott Laboratories — 2.35%
- Bristol-Myers Squibb Co — 1.84%
- Stryker Corp — 1.66%
- Medtronic PLC — 1.50%
- McKesson Corp — 1.45%
- Cigna Group/The — 1.17%
Only in VGHCX
- AstraZeneca PLC — 4.59%
- Gsk Plc — 3.00%
- Novartis AG — 1.91%
- Argenx SE — 1.68%
- Ucb Sa — 1.67%
- Agilent Technologies Inc — 1.49%
- Biogen Inc — 1.46%
- Galderma Group AG — 1.37%
- Roche Holding AG — 1.18%
- Dexcom Inc — 1.18%
Asset mix
| Asset type | VHT | VGHCX |
|---|---|---|
| Stocks | 99.8% | 97.6% |
| Repurchase agreements | — | 2.2% |
| Cash & short-term funds | 0.2% | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | VHT | VGHCX |
|---|---|---|
| US | 100.0% | 77.6% |
| GB | — | 7.6% |
| JP | — | 4.8% |
| CH | — | 4.5% |
| BE | — | 3.4% |
| DK | — | 1.4% |
| HK | — | 0.8% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do VHT and VGHCX overlap?
What stocks do VHT and VGHCX have in common?
Should I own both VHT and VGHCX?
Which holds more stocks, VHT or VGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.